Jing-Ruei Meditech

Jing-Ruei Meditech is a Taiwan-based biotechnology company specializing in precision oncology and liquid biopsy technologies. The company has developed the proprietary Cell-Life platform, an automated system designed for the high-purity isolation and enrichment of circulating tumor cells (CTCs) from blood samples. This technology enables real-time monitoring of cancer progression, treatment efficacy, and early detection of recurrence across various solid tumors, including lung, breast, and colorectal cancers. By providing a non-invasive alternative to traditional tissue biopsies, Jing-Ruei Meditech supports personalized medicine and clinical research through its advanced diagnostic tools and services.